#oritavancin

[amcrasto]

FDA approves Orbactiv to treat skin infections ....Third new antibacterial drug approved for this use this year

FDA approves Orbactiv to treat skin infections ….Third new antibacterial drug approved for this use this year

ORITAVANCIN

  August 6, 2014

Releasehttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm408475.htm

The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.

Orbactiv is approved to treat patients with acute bacterial skin and skin structure infections (ABSSSI) caused by certain susceptible…

View On WordPress

[amcrasto]

FDA Accepts Filing of NDA for IV Antibiotic Oritavancin with Priority Review

Oritavancin (4R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3-(p-(p-chlorophenyl)benzyl)vancomycin

(3S, 6R, 7R, 22R, 23S, 26S, 36R, 38aR) -22 – (3-Amino-2 ,3,6-trideoxy-3-C-methyl-alpha-L-mannopyranosyloxy) -3 – (carbamoylmethyl ) -10,19-dichloro-44-[2-O-[3 - (4'-chlorobiphenyl-4-ylmethylamino) -2,3,6-trideoxy-3-C-methyl-alpha-L-mannopyranosyl] –…

View On WordPress